Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide

PURPOSE: The phase 3 CHIASMA OPTIMAL trial (NCT03252353) evaluated efficacy and safety of oral octreotide capsules (OOCs) in patients with acromegaly who previously demonstrated biochemical control while receiving injectable somatostatin receptor ligands (SRLs). METHODS: In this double-blind study,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Endocrinol Metab
Main Authors: Samson, Susan L, Nachtigall, Lisa B, Fleseriu, Maria, Gordon, Murray B, Bolanowski, Marek, Labadzhyan, Artak, Ur, Ehud, Molitch, Mark, Ludlam, William H, Patou, Gary, Haviv, Asi, Biermasz, Nienke, Giustina, Andrea, Trainer, Peter J, Strasburger, Christian J, Kennedy, Laurence, Melmed, Shlomo
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Online Only Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7470473/
https://ncbi.nlm.nih.gov/pubmed/32882036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgaa526
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados